申请人:SHIONOGI & CO., LTD.
公开号:EP1219606A1
公开(公告)日:2002-07-03
There are provided a compound represented by the formula (I):
wherein X and X' are -N(COOCR3R2OCOR1)-, -O- or the like, R1 is alkyl substituted with carbamoyl, lower alkylcarbamoyl, carbamoyloxy, lower alkylcarbamoyloxy, acetylamino or the like, R2 and R3 are hydrogen or the like, Y and Y' are lower alkyl, lower alkenyl or the like, ring A, ring B and ring C are optionally substituted aromatic carbocycle or optionally substituted heterocycle, W1, W2 and/or W3 are a bond or the like, and V1 and V2 are a single bond or the like, or a pharmaceutically acceptable salt or a solvate thereof, as well as a pharmaceutical composition containing the present compound.
提供了一种由式(I)代表的化合物:
其中X和X'为-N(COOCR3R2OCOR1)-、-O-或类似物,R1为被氨基甲酰基、低级烷基氨基甲酰基、氨基甲酰氧基、低级烷基氨基甲酰氧基、乙酰氨基或类似物取代的烷基,R2和R3为氢或类似物,Y和Y'为低级烷基、低级烯基或类似物,环A、环 B 和环 C 是任选取代的芳香族碳环或任选取代的杂环,W1、W2 和/或 W3 是键或类似物,V1 和 V2 是单键或类似物,或其药学上可接受的盐或溶液,以及含有本化合物的药物组合物。